Brett Bade is a Respiratory physician. OpenAlex indexes 76 publications with 2,763 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559051850
Telephone
507-284-2511Provider last certified this registry record 20 Aug 2025.
Clinical trials
- Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
75.3%beta2-Adrenergic Agonist43.9%Albuterol Sulfate Hfa100%Part D≥79 patientsCorticosteroid25.9%Trelegy Ellipta44%Symbicort19%Fluticasone Propionate19%Breo Ellipta10%Budesonide-Formoterol Fumarate8%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.1%Corticosteroid7.5%Prednisone100%Part D≥28 patientsProton pump inhibitor4.6%Omeprazole100%Part D<11 patients+ 1 more class in this area
Blood & clotting
6.1%Factor Xa inhibitor6.1%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Association Between Sex and Lung Cancer Screening Adherence to Follow-Up in a Cohort of Veterans
Journal of Women s Health
2025 - Survivorship Challenges and Supportive Care in Lung Cancer
Seminars in Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”